Abstract
ObjectivesIn the GI tract, Pomegranates (Pom) ellagitannins undergo hydrolysis to ellagic acid (EA) and are further metabolized into urolithins by the gut microbiota. Both EA and UA have significant health benefits. EA is also available as dietary supplement. We aimed to compare the bioavailability of EA and its biotransformation to UA between pure EA and Pom juice (PomJ). Methods17 healthy male participants were randomly assigned to take a single dose of 8 oz of PomJ or 500 mg of EA, followed by 2-week washout, and crossover to the other intervention. We collected blood prior and 1 and 2 h after consumption of EA or PomJ and urine for 24hours. Plasma concentration of EA was measured using HPLC. Urinary EA metabolites (DMEAG and UAG) were determined by LC/MS and normalized to urine creatinine levels. Circulating MCP1, insulin and leptin were analyzed using the multiplex human cytokine panel (Millipore). ResultsThere was no difference in plasma EA concentration after administration of PomJ versus 500 mg EA. Urinary DMEAG, normalized to creatinine, was significantly higher after PomJ compared to EA intake (PomJ: 0.11 + 0.02; EA: 0.05 + 0.01 μg/mg; P < 0.05). Urinary UAG was present in 13 participants and 4 out of 17 subjects did not have the ability to convert EA to UA after consumption of either pure EA vs. PomJ. Blood glucose at 2 hrs decreased –5.53% ± 1.61% (p = 0.01) and insulin at 1 hr increased 95.74% ± 37.44% (p < 0.05) after PomJ consumption compared to baseline. Blood MCP1 decreased –15.51% ± 6.11% (p < 0.05) 2 hrs after PomJ, and leptin was significantly decreased (PomJ: –17.13% ± 4.64% (p < 0.00); EA: –18.80% ± 2.93% (p < 0.00)) 2 hrs after PomJ and EA consumption. Conclusions8 oz of PomJ provides an equivalent source of EA and microbial mediated biotransformation of EA to UA compared to 500 mg EA supplement. However, an increase in phase II metabolism of EA and acute effect on plasma MCP1 was only observed following PomJ consumption. Funding SourcesCenter for Human Nutrition, David Geffen School of Medicine at UCLA, Los Angeles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.